T2 Biosystems Revenue and Competitors

Boston, MA USA

Location

$255.8M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • T2 Biosystems's estimated annual revenue is currently $33.6M per year.(i)
  • T2 Biosystems's estimated revenue per employee is $188,961
  • T2 Biosystems's total funding is $255.8M.

Employee Data

  • T2 Biosystems has 178 Employees.(i)
  • T2 Biosystems grew their employee count by -13% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$7M4573%N/AN/A
#10
$5.4M353%N/AN/A
Add Company

T2 Biosystems is a private biotechnology company developing next-generation medical diagnostic products using its proprietary technology, combining nanotechnology and miniaturized magnetic resonance (MRI) technology to provide rapid, accurate and portable diagnostics. T2 Biosystems was founded in 2006 by renowned researchers from the Massachusetts Institute of Technology, Harvard University, Harvard Medical School and Massachusetts General Hospital, and has assembled a world-class team, board of directors and scientific advisory board that collectively have a proven track record of translating technologic innovations into breakthrough products, building significant corporate value. T2 Biosystems is located in Cambridge, Massachusetts

keywords:Healthcare

$255.8M

Total Funding

178

Number of Employees

$33.6M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

T2 Biosystems's People

NameTitleEmail/Phone
1
VP, US SalesReveal Email/Phone
2
Regional Sales Director - WestReveal Email/Phone
3
Director, Cost AccountingReveal Email/Phone
4
General CounselReveal Email/Phone
5
Manager, Quality Management SystemsReveal Email/Phone
6
SalesReveal Email/Phone
7
Accounts Payable ManagerReveal Email/Phone
8
VP Science Research and DevelopmentReveal Email/Phone
9
Senior Director QualityReveal Email/Phone
10
Regional Account ManagerReveal Email/Phone

T2 Biosystems News

2022-04-17 - T2 Biosystems Inc (TTOO) Stock Has Fallen -7.84% This Week: Buy, Hold, or Sell?

T2 Biosystems Inc (TTOO) stock is lower by -62.99% over the last 12 months. InvestorsObserver's proprietary ranking system, gives TTOO stock...

2022-03-30 - T2 Biosystems Announces BARDA Exercise of Contract ...

T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient...

2022-03-22 - T2 Biosystems to Host Analyst and Investor Day on April 12 ...

T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient...

2021-10-07 - T2 Biosystems : Development of a rapid, high sensitivity, direct from blood assay for identification of biothreat organisms

Development of a rapid, high sensitivity, direct from blood assay for identification of biothreat organisms Robert P. Shivers, Daniel Gamero, Kristen M. Roberts, Benjamin Chang, Alicyn R. Pearson, Judy Pacheco, Michael Min, Heather S. Lapp, Nabuan Nafer, Jessica Snyder, and Roger Smith T2 Bio ...

2016-09-22 - T2 Biosystems Announces $40 Million Equity Investment by Partner Canon U.S.A.

LEXINGTON, Mass., Sept. 22, 2016 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced the purchase by Canon U.S.A., of approximately $40 million of the company’s stock in a private placement. The shar ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$29M1823%N/A
#2
$58.7M1845%N/A
#3
$15M184-16%$69M
#4
$62.1M18529%N/A
#5
$15M1850%N/A